Top Mid Cap Stocks Worth Watching – April 11th

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Charles River Laboratories International, Recursion Pharmaceuticals, and United States Steel are the five Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid cap stocks are shares of companies with a market capitalization typically between $2 billion and $10 billion. They often strike a balance between the stability of large cap stocks and the growth potential of small cap stocks, offering investors a blend of moderate risk and opportunity for expansion. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

ProShares UltraPro Short QQQ stock traded down $1.96 during trading on Friday, reaching $36.25. The company had a trading volume of 126,140,279 shares, compared to its average volume of 46,759,242. The stock’s 50 day moving average price is $34.58 and its two-hundred day moving average price is $33.26. ProShares UltraPro Short QQQ has a 12-month low of $26.21 and a 12-month high of $64.95.

Direxion Daily TSLA Bull 2X Shares (TSLL)

TSLL traded down $0.31 during trading on Friday, hitting $8.14. 172,415,762 shares of the company’s stock were exchanged, compared to its average volume of 77,936,973. The firm has a market cap of $3.55 billion, a P/E ratio of 47.43 and a beta of -5.14. The stock has a 50 day moving average price of $13.03 and a 200 day moving average price of $18.62. Direxion Daily TSLA Bull 2X Shares has a 1 year low of $4.94 and a 1 year high of $41.50.

Charles River Laboratories International (CRL)

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing).

Shares of NYSE:CRL traded down $1.10 during mid-day trading on Friday, hitting $98.85. 9,124,058 shares of the company traded hands, compared to its average volume of 845,532. The firm’s 50 day simple moving average is $157.97 and its 200 day simple moving average is $177.65. The firm has a market cap of $4.85 billion, a P/E ratio of 656.79, a PEG ratio of 4.54 and a beta of 1.45. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.14 and a current ratio of 1.41. Charles River Laboratories International has a 52-week low of $92.05 and a 52-week high of $254.15.

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers.

Shares of RXRX traded up $1.06 during mid-day trading on Friday, reaching $5.57. 72,720,275 shares of the stock traded hands, compared to its average volume of 11,669,549. The stock has a fifty day simple moving average of $6.87 and a 200 day simple moving average of $6.84. Recursion Pharmaceuticals has a 12-month low of $3.79 and a 12-month high of $12.36. The company has a quick ratio of 4.35, a current ratio of 4.35 and a debt-to-equity ratio of 0.04. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -3.63 and a beta of 1.00.

United States Steel (X)

United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe. The company operates through North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular) segments. The Flat-Rolled segment offers slabs, strip mill plates, sheets, and tin mill products, as well as iron ore and coke.

X traded down $0.83 during trading hours on Friday, reaching $40.04. 9,422,004 shares of the stock traded hands, compared to its average volume of 5,403,755. United States Steel has a fifty-two week low of $26.92 and a fifty-two week high of $46.18. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.55 and a quick ratio of 0.91. The company has a market cap of $9.07 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 1.53 and a beta of 1.79. The firm’s fifty day simple moving average is $39.80 and its two-hundred day simple moving average is $37.62.